Ultragenyx Pharmaceutical Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Okay. Welcome, everybody. I am your guide this next 30 minutes with Ultragenyx. I'm Marty Auster. I'm the lead Smid cap biotech analyst at Crédit Suisse. Welcome to our Ultragenyx fireside chat at the 29th Annual Crédit Suisse Healthcare Conference and the first virtual one.
I've got Dr. Emil Kakkis here, the CEO and Founder of Ultragenyx. I want to thank everyone for joining us today. If anybody had any questions during this fireside, I'm happy to work those into the conversation. Shoot me an e-mail. There should be a tab on your screen to do so or just send me an e-mail straight through, and I'll check and get to them during the fireside.
Questions & Answers
© -
Emil, let me hand it over to you, and let me start with -- I noticed when I was prepping questions for this, that you guys are a decade in as of this summer. I'm curious what
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |